A Perspective on Synthetic Biology in Drug Discovery and Development-Current Impact and Future Opportunities

被引:10
|
作者
David, Florian [1 ]
Davis, Andrew M. [2 ]
Gossing, Michael [3 ]
Hayes, Martin A. [3 ]
Romero, Elvira [3 ]
Scott, Louis H. [3 ]
Wigglesworth, Mark J. [4 ]
机构
[1] Chalmers Univ Technol, Dept Biol & Biol Engn, Div Syst & Synthet Biol, Gothenburg, Sweden
[2] AstraZeneca, Biopharmaceut R&D, Discovery Sci, 310 Milton Rd, Cambridge CB4 0WG, England
[3] AstraZeneca, Biopharmaceut R&D, Discovery Sci, Gothenburg, Sweden
[4] AstraZeneca, Biopharmaceut R&D, Discovery Sci, Alderley Pk, Macclesfield, Cheshire, England
关键词
biofoundry; chassis organism; CRISPR-Cas9; drug discovery; late-stage functionalization; synthetic biology; PROTEIN-PROTEIN INTERACTIONS; BIOSYNTHETIC GENE-CLUSTER; CYCLIC PEPTIDE INHIBITOR; DIRECTED EVOLUTION; SACCHAROMYCES-CEREVISIAE; NATURAL-PRODUCTS; SEMISYNTHETIC ARTEMISININ; ENGINEERING STRATEGIES; BINDING-PROTEIN; CELL FACTORIES;
D O I
10.1177/24725552211000669
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The global impact of synthetic biology has been accelerating, because of the plummeting cost of DNA synthesis, advances in genetic engineering, growing understanding of genome organization, and explosion in data science. However, much of the discipline's application in the pharmaceutical industry remains enigmatic. In this review, we highlight recent examples of the impact of synthetic biology on target validation, assay development, hit finding, lead optimization, and chemical synthesis, through to the development of cellular therapeutics. We also highlight the availability of tools and technologies driving the discipline. Synthetic biology is certainly impacting all stages of drug discovery and development, and the recognition of the discipline's contribution can further enhance the opportunities for the drug discovery and development value chain.
引用
收藏
页码:581 / 603
页数:23
相关论文
共 50 条
  • [41] Peptide Developability at the Discovery-to-Development Interface-Current State and Future Opportunities
    Bak, Annette
    Dai, Weiguo
    AAPS JOURNAL, 2015, 17 (04): : 777 - 779
  • [42] Impact of drug discovery on stem cell biology
    Zhang, Xiu-Zhen
    Li, Xue-Juan
    Ji, Hong-Fang
    Zhang, Hong-Yu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 383 (03) : 275 - 279
  • [43] Systems biology impact on antiepileptic drug discovery
    Margineanu, Doru Georg
    EPILEPSY RESEARCH, 2012, 98 (2-3) : 104 - 115
  • [44] Anticancer drug discovery in the future: an evolutionary perspective
    Ma, Xianghui
    Wang, Zhiwen
    DRUG DISCOVERY TODAY, 2009, 14 (23-24) : 1136 - 1142
  • [45] Neuropsychiatric drug development: Perspectives on the current landscape, opportunities and potential future directions
    Loiodice, Simon
    D'Acquisto, Fulvio
    Drinkenburg, Pim
    Suojanen, Christian
    Llorca, Pierre-Michel
    Manji, Husseini K.
    DRUG DISCOVERY TODAY, 2025, 30 (01)
  • [46] Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective
    Wong, Erik H. F.
    Yocca, Frank
    Smith, Mark A.
    Lee, Chi-Ming
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (09): : 1269 - 1284
  • [47] Quantitative Systems Pharmacology for Neuroscience Drug Discovery and Development: Current Status, Opportunities, and Challenges
    Geerts, Hugo
    Wikswo, John
    van der Graaf, Piet H.
    Bai, Jane P. F.
    Gaiteri, Chris
    Bennett, David
    Swalley, Susanne E.
    Schuck, Edgar
    Kaddurah-Daouk, Rima
    Tsaioun, Katya
    Pelleymounter, Mary
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (01): : 5 - 20
  • [48] Opportunities to minimise risk in drug discovery and development
    Swinney, David C.
    EXPERT OPINION ON DRUG DISCOVERY, 2006, 1 (07) : 627 - 633
  • [49] Drug discovery and development for ageing: opportunities and challenges
    Evans, William J.
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2011, 366 (1561) : 113 - 119
  • [50] Opportunities and Challenges in the Anticandidal Drug Discovery and Development
    Abid, Mohammad
    LETTERS IN DRUG DESIGN & DISCOVERY, 2019, 16 (05) : 477 - 477